Diorasis Therapeutics
Pre-clinicalGlaucoma is the leading cause of irreversible blindness, affecting about 3 million Americans and 80 million people worldwide. It is mainly caused by high pressure inside the eye.
Founded
2020
Focus
RNA & Gene Therapy
About
Glaucoma is the leading cause of irreversible blindness, affecting about 3 million Americans and 80 million people worldwide. It is mainly caused by high pressure inside the eye.
Company Info
TypePrivate
Founded2020
LocationBoston, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile